Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: Systematic review

BMJ

Volumn 342, Issue 7798, 2011, Pages 639-

  Moschetti, Ivan ^a   Brandt, Daniel ^b   Perera, Rafael ^a   Clarke, M ^c   Heneghan, Carl ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INFORMATION PROCESSING; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; LIPIDS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SMOKING;

EID: 79952823679     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d1289     Document Type: Review

References (25)

1. Altman DG, Simera I, Hoey J, Moher D, Schutz K. EQUATOR: reporting guidelines for health research. Lancet 2008;371:1149-50. (Pubitemid 351467721)
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
3. Emberson JR, Whincup PH, Morris RW, Walker M. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J 2003;24:1719-26. (Pubitemid 37236860)
4. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, et al. Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 2010;170:27-40.
5. Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A. Monitoring cholesterol levels: measurement error or true change? Ann Intern Med 2008;148:656-61.
6. US Department of Health and Human Services. Medicare national coverage determinations, manual coverage determinations. 2010. https://www.cms.gov/ manuals/downloads/ncd103c1-Part3.pdf.
7. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005;330:644-8. (Pubitemid 40444763)
8. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
9. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14(suppl 2):E1-40S.
10. Canadian Stroke Network and the Heart and Stroke Foundation of Canada. Canadian best practice recommendations for stroke care. Canadian Stroke Network and the Heart and Stroke Foundation of Canada, 2006.
11. Campbell-Scherer DL, Campbell-Scherer DL, Green LA. ACC/AHA guideline update for themanagement of ST-segment elevation myocardial infarction. Am Fam Physician 2009;79:1080-6.
12. Fulcher GR, Amarena JV, Conner GW, Gilbert RE, Hankey GJ. Prevention of cardiovascular disease: an evidence-based clinical aid 2004. Med J Aust 2004;181(suppl 6):F4-14S.
13. NCEP Expert Panel. Third report of the National Cholesterol Education Program(NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III), final report. Circulation 2002;106:3143-421.
14. University of Michigan Health System. Management of type 2 diabetes mellitus: guidelines for clinical care. 2008. http://cme.med.umich.edu/pdf/ guideline/dm08.pdf.
15. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006;113:e873-923.
16. JBS 2. Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl 5):v1-52S.
17. National Vascular Disease Prevention Alliance. Consensus statement for the prevention of vascular disease. Aust Fam Physician 2004;33:235-9.
18. British Columbia Medical Association. Cardiovascular disease - primary prevention guidelines and protocols. 2008. www.bcguidelines.ca/gpac/pdf/cvd.pdf.
19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
20. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115:114-26. (Pubitemid 46058619)
21. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72.
22. University of Michigan Health System. Secondary prevention of coronary artery disease. 2009. http://cme.med.umich.edu/pdf/guideline/cad.pdf.
23. SIGN. Risk estimation and the prevention of cardiovascular disease: N 97. 2007. www.sign.ac.uk.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52. (Pubitemid 37553153)
25. Burgers JS, Cluzeau FA, Hanna SE, Hunt C, Grol R. Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada. Int J Technol Assess Health Care 2003;19:148-57. (Pubitemid 36356335)